
About Optio Rx
Optio Rx is a Healthcare company based in Nashville (United States) founded in 2018. Provider of drug compounding and patient consultation services. Its focus areas include Services for Healthcare Providers, BPO, Outsourced Clinical Services and Drug Compounding. Its competitors include Fagron, Revelation Pharma and Syntis; 1 of its 3 listed competitors has raised funding.
Company details
Optio Rx provider of drug compounding and patient consultation services through providing healthcare solutions, services for healthcare providers, bpo, outsourced clinical services, and drug compounding. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Nashville, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website optiorx.com
- Investors
Funding Insights of Optio Rx
- Total Rounds 2
- Investors Count 1
All 2 funding rounds of Optio Rx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | Debt – Conventional | β | β | ||
| Jul 2018 | Seed | β | β |
1 investors in total: 1 institutional.
Investors in Optio Rx
Optio Rx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Capitala Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global multi-sector investments are managed by the private equity firm. | capitalagroup.com | Charlotte, United States |
Investor details for Optio Rx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Optio Rx
5 people are tracked at Optio Rx (2 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Robert Stricklin, M.B.A. | Director of Financial Planning and Analysis | Leadership |
Leo LaFranco | Chief Financial Officer | Leadership |
Jon Finch | Member - Board Of Directors | Team |
Vincent Schettino | OptioRx Territory Sales Representative | Team |
Matt Goller | Business Development Manager | Team |
Complete people profiles for Optio Rx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Optio Rx
2 dated milestones of Optio Rx, from founding to its latest funding, stage changes and deals.
- Founded Optio Rx is founded.
- Funding First funding round.
Competitors of Optio Rx
Optio Rx has 3 listed competitors in our database, 1 of them funded. They include Fagron, Revelation Pharma and Syntis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fagron.com | 1990 | Saint Paul, United States | 3,315 | Drug compounding services are provided by Fagron. | ||
| revcustomrx.com | 2020 | Greenwood Village, United States | A network of compounding pharmacies is operated nationwide. | |||
| syntis.bio | 2021 | Boston, United States | $65.88M | Drug compounding services are provided by Syntis in healthcare. |
Detailed competitors of Optio Rx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Optio Rx
The website of Optio Rx (optiorx.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 52.7% vs previous month
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as Optio Rx (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Optio Rx
Optio Rx was founded in 2018.
Optio Rx is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Optio Rx provider of drug compounding and patient consultation services through providing healthcare solutions, services for healthcare providers, bpo, outsourced clinical services, and drug compounding. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Optio Rx's top competitors include Syntis, Fagron and Revelation Pharma.
Optio Rx has 1 investor. Key investors include Capitala Group.